Hangzhou TianMuShan Pharmaceutical Enterprise Co. Ltd. provided earnings guidance for the full year of 2018. The company predicts a decrease of between RMB 15,141,600 and RMB 17,641,600 in its net profit owned by shareholders of the company in 2018 compared with the same period of the year before, with a year-on-year decrease of between 185.98% and 216.69%. The net profit belonging to shareholders of the company after excluding extraordinary profit and loss will be between negative of RMB 26,293,700 and RMB 23,793,700.